Audiologists in Auburn, WA Accepting Medicare

2 Audiologists found. Showing 1 - 2

Trista Elizabeth Smith, AUD, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 222 2nd St Ne, Auburn, WA 98002 Phone: 253-833-4050

Susan L Harris Audiologist Medicare: Accepting Medicare Assignments Practice Location: 310 6th St Ne, Auburn, WA 98002 Phone: 253-833-6241    Fax: 253-833-4113

News Archive

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.

Wine, beer and spirits all equal when it comes to breast cancer

Barcelona, Spain: One of the largest individual studies of the effects of alcohol on the risk of breast cancer has concluded that it makes no difference whether a woman drinks wine, beer or spirits (liquor) – it is the alcohol itself (ethyl alcohol) and the quantity consumed that is likely to trigger the onset of cancer.

From Florida to Oregon, Medicare Advantage's benefits – and cuts – vary

This Kaiser Health News story by David Gulliver, produced in partnership with Health News Florida, explores how the impact of changes to Medicare Advantage will differ from place to place across the country.

Lack of sleep tied to greater risk of heart disease

Sleeping less than seven and a half hours per day may be associated with future risk of heart disease, according to a report in the November 10 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.

Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company

Entos Pharmaceuticals Inc. ("Entos" or the "Company"), a healthcare biotechnology company focused on the development of next-generation nucleic acid-based therapies using their Fusogenix drug delivery platform, today announced it has entered into a research, development and collaboration agreement ("Agreement") with a clinical stage biopharmaceutical company ("Partner") focused on the development of novel therapeutic compounds targeting autoimmune and inflammatory diseases.

Read more Medical News

› Verified 4 days ago